HER-2/neu raises SHP-2, stops IFN-γ anti-proliferation in bladder cancer

Wen-Pin Su, I. Hwi Tu, Shiao Wen Hu, Hsuan Heng Yeh, Dar-Bin Shieh, Tsai-Yun Chen, Wu-Chou Su

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Gene amplification or HER-2/neu protein overexpression signals a poor outcome for bladder cancer patients. We investigated the anti-proliferative effect of IFN-γ in HER-2/neu-transfected human bladder cancer cells (TCC-N5 and TCC-N10). The cells continued growing after IFN-γ stimulation but did not activate the Janus kinase (Jak)/Stat pathway. We found Jak/Stat protein phosphatase in TCC-N5 and TCC-N10 cells with upregulated Src homology 2-containing protein tyrosine phosphatase-2 (SHP-2). After the cells had been treated with AG825, a HER-2/neu-specific inhibitor, SHP-2 expression declined, and Jak2/Stat1 reactivated. Similar results were reported in a mouse bladder cancer cell line, MBT2, with constitutive HER-2/neu overexpression. Further, AG825 pretreatment restored the anti-proliferation activity of IFN-γ in TCC-N5 and TCC-N10 cells. Therefore, the suppression of IFN-γ signaling in HER-2/neu-overexpressing bladder cancer cells might be due to SHP-2 upregulation. The regulation of SHP-2 by HER-2/neu provides a new target for blocking the HER-2/neu oncogenic pathway.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume356
Issue number1
DOIs
Publication statusPublished - 2007 Apr 27

Fingerprint

Urinary Bladder Neoplasms
Janus Kinases
Cells
Non-Receptor Type 11 Protein Tyrosine Phosphatase
Phosphoprotein Phosphatases
Gene Amplification
Proteins
Up-Regulation
Cell Line
tyrphostin AG825

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{45a1e239c06144369d6263f2cc72607e,
title = "HER-2/neu raises SHP-2, stops IFN-γ anti-proliferation in bladder cancer",
abstract = "Gene amplification or HER-2/neu protein overexpression signals a poor outcome for bladder cancer patients. We investigated the anti-proliferative effect of IFN-γ in HER-2/neu-transfected human bladder cancer cells (TCC-N5 and TCC-N10). The cells continued growing after IFN-γ stimulation but did not activate the Janus kinase (Jak)/Stat pathway. We found Jak/Stat protein phosphatase in TCC-N5 and TCC-N10 cells with upregulated Src homology 2-containing protein tyrosine phosphatase-2 (SHP-2). After the cells had been treated with AG825, a HER-2/neu-specific inhibitor, SHP-2 expression declined, and Jak2/Stat1 reactivated. Similar results were reported in a mouse bladder cancer cell line, MBT2, with constitutive HER-2/neu overexpression. Further, AG825 pretreatment restored the anti-proliferation activity of IFN-γ in TCC-N5 and TCC-N10 cells. Therefore, the suppression of IFN-γ signaling in HER-2/neu-overexpressing bladder cancer cells might be due to SHP-2 upregulation. The regulation of SHP-2 by HER-2/neu provides a new target for blocking the HER-2/neu oncogenic pathway.",
author = "Wen-Pin Su and Tu, {I. Hwi} and Hu, {Shiao Wen} and Yeh, {Hsuan Heng} and Dar-Bin Shieh and Tsai-Yun Chen and Wu-Chou Su",
year = "2007",
month = "4",
day = "27",
doi = "10.1016/j.bbrc.2007.02.099",
language = "English",
volume = "356",
pages = "181--186",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

HER-2/neu raises SHP-2, stops IFN-γ anti-proliferation in bladder cancer. / Su, Wen-Pin; Tu, I. Hwi; Hu, Shiao Wen; Yeh, Hsuan Heng; Shieh, Dar-Bin; Chen, Tsai-Yun; Su, Wu-Chou.

In: Biochemical and Biophysical Research Communications, Vol. 356, No. 1, 27.04.2007, p. 181-186.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HER-2/neu raises SHP-2, stops IFN-γ anti-proliferation in bladder cancer

AU - Su, Wen-Pin

AU - Tu, I. Hwi

AU - Hu, Shiao Wen

AU - Yeh, Hsuan Heng

AU - Shieh, Dar-Bin

AU - Chen, Tsai-Yun

AU - Su, Wu-Chou

PY - 2007/4/27

Y1 - 2007/4/27

N2 - Gene amplification or HER-2/neu protein overexpression signals a poor outcome for bladder cancer patients. We investigated the anti-proliferative effect of IFN-γ in HER-2/neu-transfected human bladder cancer cells (TCC-N5 and TCC-N10). The cells continued growing after IFN-γ stimulation but did not activate the Janus kinase (Jak)/Stat pathway. We found Jak/Stat protein phosphatase in TCC-N5 and TCC-N10 cells with upregulated Src homology 2-containing protein tyrosine phosphatase-2 (SHP-2). After the cells had been treated with AG825, a HER-2/neu-specific inhibitor, SHP-2 expression declined, and Jak2/Stat1 reactivated. Similar results were reported in a mouse bladder cancer cell line, MBT2, with constitutive HER-2/neu overexpression. Further, AG825 pretreatment restored the anti-proliferation activity of IFN-γ in TCC-N5 and TCC-N10 cells. Therefore, the suppression of IFN-γ signaling in HER-2/neu-overexpressing bladder cancer cells might be due to SHP-2 upregulation. The regulation of SHP-2 by HER-2/neu provides a new target for blocking the HER-2/neu oncogenic pathway.

AB - Gene amplification or HER-2/neu protein overexpression signals a poor outcome for bladder cancer patients. We investigated the anti-proliferative effect of IFN-γ in HER-2/neu-transfected human bladder cancer cells (TCC-N5 and TCC-N10). The cells continued growing after IFN-γ stimulation but did not activate the Janus kinase (Jak)/Stat pathway. We found Jak/Stat protein phosphatase in TCC-N5 and TCC-N10 cells with upregulated Src homology 2-containing protein tyrosine phosphatase-2 (SHP-2). After the cells had been treated with AG825, a HER-2/neu-specific inhibitor, SHP-2 expression declined, and Jak2/Stat1 reactivated. Similar results were reported in a mouse bladder cancer cell line, MBT2, with constitutive HER-2/neu overexpression. Further, AG825 pretreatment restored the anti-proliferation activity of IFN-γ in TCC-N5 and TCC-N10 cells. Therefore, the suppression of IFN-γ signaling in HER-2/neu-overexpressing bladder cancer cells might be due to SHP-2 upregulation. The regulation of SHP-2 by HER-2/neu provides a new target for blocking the HER-2/neu oncogenic pathway.

UR - http://www.scopus.com/inward/record.url?scp=33947267984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947267984&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2007.02.099

DO - 10.1016/j.bbrc.2007.02.099

M3 - Article

VL - 356

SP - 181

EP - 186

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -